Evidence map›Paper›PMID 34881912›Full record

Trial reportJournal of consulting and clinical psychology2021

Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.

J Cobb Scott, Kevin G Lynch, David P Cenkner, Shannon M Kehle-Forbes, Melissa A Polusny, Ruben C Gur, Shirley Chen, Edna B Foa, David W Oslin

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of consulting and clinical psychology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

J Cobb ScottVISN4 Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, MIRECC/116.ORCID 0000-0001-6538-9043
Kevin G LynchDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania.
David P CenknerVISN4 Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, MIRECC/116.
Shannon M Kehle-ForbesNational Center for PTSD Women's Health Sciences Division, VA Boston Healthcare System.
Melissa A PolusnyNational Center for PTSD Women's Health Sciences Division, VA Boston Healthcare System.
Ruben C GurDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania.
Shirley ChenVISN4 Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, MIRECC/116.
Edna B FoaDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania.
David W OslinVISN4 Mental Illness Research, Education, and Clinical Center, Corporal Michael J. Crescenz VA Medical Center, MIRECC/116.
Mental Illness Research, Education and Clinical Centers · USUniversity of Pennsylvania · USVA Boston Healthcare System · US

Funding

CSRD VA ZDA1-03-W10RRD VA I01 RX002699VA
6 · The paper itself

Abstract

objectiveComorbidity between posttraumatic stress disorder (PTSD) and substance use disorders (SUD) is common, and both are associated with cognitive dysfunction. However, few studies examine the impact of cognitive deficits on treatment outcomes. Here, we leverage data from a randomized clinical trial of integrated versus phased psychotherapy for SUD and PTSD to examine the relation of cognitive functioning to treatment response.

methodOne-hundred and thirteen veterans with co-occurring PTSD and SUD completed Penn Computerized Neurocognitive Battery tests assessing attention, executive control, memory, and spatial processing. Linear mixed-effects models examined interactions between cognitive functioning and time in predicting primary PTSD and SUD outcomes across both treatments.

resultsSignificant verbal immediate memory by time interactions were found for both PTSD symptoms (p = .01, f 2 = 0.020) and percent heavy drinking or drug use days (p = .004, f 2 = 0.020). There was a significant working memory by time interaction for percent heavy drinking or drug use days (p = .007, f 2 = 0.016). Participants with better verbal memory had greater reductions across time in PTSD symptoms and drinking/drug use, while those with better working memory had lesser reductions in their drinking/drug use across time.

conclusionsIndividuals with lower verbal memory functioning had less robust PTSD and SUD symptom reductions in PTSD/SUD psychotherapy, with differences that were generally small in magnitude. Those with better working memory functioning had worse SUD outcomes. Together with prior literature, findings suggest that neurocognitive functioning may impact the effectiveness of PTSD and SUD treatment. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Indexed as

Stress Disorders, Post-TraumaticSubstance-Related DisordersVeteransComorbidityHumansPsychotherapyTreatment Outcome

Identifiers

PMID34881912
PMCPMC9465807
OpenAlexW4200365993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.